Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD)

www.Melody.education is the premier, online central source and community wherein multidisciplinary healthcare providers deliver and experience the most up-to-date information, data and resources on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD). With our Clinical Experts Faculty we produce: Webconferences, Strategies for Optimal Outcomes, Case Studies, Audience Questions and Faculty Answers.

PLAY ON CASTBOX

Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Welcome and Introduction

Part 1: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Welcome and Introduction with Prof Michael Trauner

05-09
05:54

Prof Jörn Schattenberg presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: NASH: A Growing Unmet Therapeutic Need

Part 2: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: NASH: A Growing Unmet Therapeutic Need with Prof Jörn Schattenberg

05-09
12:08

Prof Meena Bansal, MD presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: The Underestimated Importance of Thyroid Hormone Pathway in the Pathophysiology of NASH

Part 3: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: The Underestimated Importance of Thyroid Hormone Pathway in the Pathophysiology of NASH with Prof Meena Bansal, MD

05-09
11:46

Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Closing

Part 4: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Closing with Prof Michael Trauner

05-09
02:03

Scott Isaacs, MD, FACE, FACP and Barton Isaac, PharmD present: NASH Patient Identification, Referral and Management in Endocrinology and Hepatology Practices

NASH Patient Identification, Referral and Management in Endocrinology and Hepatology Practices with Scott Isaacs, MD, FACE, FACP and Barton Isaac, PharmD

05-02
12:36

Keith Miller, PhD presents: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Introduction

Part 1: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Introduction with Keith Miller, PhD

11-24
00:44

Christina Hanson, MS, FNP presents: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Definitions and Epidemiology; Pathophysiology; Natural History of the Disease; Morbidity and Mortality

Part 2: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Definitions and Epidemiology; Pathophysiology; Natural History of the Disease; Morbidity and Mortality with Christina Hanson, MS, FNP

11-24
11:51

Ann Moore, FNP-C presents: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Identifying Risk Factors; Patient Identification; Patient Perspective

Part 3: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Identifying Risk Factors; Patient Identification; Patient Perspective with Ann Moore, FNP-C

11-24
27:14

Prof Quentin M. Anstee presents Part 1: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

Part 1: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives with Prof Quentin M. Anstee (presented at EASL 2022)

10-27
20:32

Jörn M. Schattenberg, MD presents Part 2: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

Part 2: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives with Jörn M. Schattenberg, MD (presented at EASL 2022)

10-27
13:06

Stephen A. Harrison, MD, FACP, FAASLD presents Part 3: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

Part 3: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives with Stephen A. Harrison, MD, FACP, FAASLD (presented at EASL 2022)

10-27
23:53

Prof Quentin M. Anstee, Jörn M. Schattenberg, MD, and Stephen A. Harrison, MD, FACP, FAASLD present Part 4: Q&A - Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022: Q&A

Part 4: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives: Q&A with Prof Quentin M. Anstee, Jörn M. Schattenberg, MD, and Stephen A. Harrison, MD, FACP, FAASLD (presented at EASL 2022)

10-27
18:34

Mazen Noureddin, MD, MHSc presents Part 1: Emerging Concepts in Non-Alcoholic Steatohepatitis (NASH): Disease Education Program as presented at CLDF 2022

Part 1: Emerging Concepts in Non-Alcoholic Steatohepatitis (NASH): Disease Education Program with Mazen Noureddin, MD, MHSc (presented at CLDF 2022)

06-09
19:24

Marcelo Kugelmas, MD, FAASLD, FACP presents Part 2: Emerging Concepts in Non-Alcoholic Steatohepatitis (NASH): Disease Education Program as presented at CLDF 2022

Part 2: Emerging Concepts in Non-Alcoholic Steatohepatitis (NASH): Disease Education Program with Marcelo Kugelmas, MD, FAASLD, FACP (presented at CLDF 2022)

06-09
23:38

Mazen Noureddin, MD, MHSc, and Marcelo Kugelmas, MD, FAASLD, FACP present Part 3: Emerging Concepts in Non-Alcoholic Steatohepatitis (NASH): Disease Education Program: Q&A as presented at CLDF 2022

Part 3: Emerging Concepts in Non-Alcoholic Steatohepatitis (NASH): Disease Education Program: Q&A with Mazen Noureddin, MD, MHSc, and Marcelo Kugelmas, MD, FAASLD, FACP (presented at CLDF 2022)

06-09
06:04

Scott L. Friedman, MD and Wayne Eskridge present: Patient Video Series in Partnership with the Fatty Liver Foundation: Fatty Liver Foundation Development

Part 1: Fatty Liver Foundation Development with Scott L. Friedman, MD and Wayne Eskridge

01-07
11:19

Scott L. Friedman, MD and Wayne Eskridge present Part 2: Patient Video Series in Partnership with the Fatty Liver Foundation: Advice for Patients with Recent Diagnosis of NASH with Fibrosis

Part 2: Advice for Patients with Recent Diagnosis of NASH with Fibrosis with Scott L. Friedman, MD and Wayne Eskridge

01-07
15:42

Scott L. Friedman, MD and Wayne Eskridge present Part 3: Patient Video Series in Partnership with the Fatty Liver Foundation: After Diagnosis: What Happens Now?

Part 3: After Diagnosis: What Happens Now? with Scott L. Friedman, MD and Wayne Eskridge

01-07
11:33
View All on Castbox

Recommend Channels